BACKGROUND: The chronic myeloproliferative diseases (CMPDs) include chronic myelogenous leukemia (CML), primary (essential) thrombocythemia (PT), agnogenic myeloid metaplasia (AMM), and polycythemia vera (PV). Certain hematological malignancies have a different prevalence in our country than in countries with Caucasian populations. Data indicate that the prevalence of CML in our country is similar to that found in Caucasians; however, the prevalence of the other CMPDs has not been studied. METHODS: In a total of 8069 individuals studied between June 1983 and March 2001 in the Centro de Hematologia y Medicina Interna de Puebla, we assessed the prevalence of CML, PT, AMM, and PV. Some of the clinical features of these individuals were also assessed. RESULTS AND CONCLUSIONS: Forty-nine patients with CML, 14 with PT, 7 with AMM, and 3 with PV were identified. The clinical presentations of these CMPDs were not different from those described in Caucasians. CONCLUSIONS: We found that CML was more than 3 times more frequent than PT, that both PV and AMM were exceptional, and that PT, AMM, and PV were significantly less frequent in Mexican than in Caucasian populations (P < .01).
BACKGROUND: The chronic myeloproliferative diseases (CMPDs) include chronic myelogenous leukemia (CML), primary (essential) thrombocythemia (PT), agnogenic myeloid metaplasia (AMM), and polycythemia vera (PV). Certain hematological malignancies have a different prevalence in our country than in countries with Caucasian populations. Data indicate that the prevalence of CML in our country is similar to that found in Caucasians; however, the prevalence of the other CMPDs has not been studied. METHODS: In a total of 8069 individuals studied between June 1983 and March 2001 in the Centro de Hematologia y Medicina Interna de Puebla, we assessed the prevalence of CML, PT, AMM, and PV. Some of the clinical features of these individuals were also assessed. RESULTS AND CONCLUSIONS: Forty-nine patients with CML, 14 with PT, 7 with AMM, and 3 with PV were identified. The clinical presentations of these CMPDs were not different from those described in Caucasians. CONCLUSIONS: We found that CML was more than 3 times more frequent than PT, that both PV and AMM were exceptional, and that PT, AMM, and PV were significantly less frequent in Mexican than in Caucasian populations (P < .01).
Authors: D D Alemán-Hoey; G J Ruiz-Argüelles; L Verduzco-Rodríguez; B López-Ariza; J R Labardini Journal: Rev Invest Clin Date: 1982 Apr-Jun Impact factor: 1.451
Authors: G J Ruiz-Argüelles; B López-Martínez; J M Ramírez-Cabrera; V Reyes-Núñez; H M Rodríguez-Cedeño; J Garcés-Eisele Journal: Rev Invest Clin Date: 2001 May-Jun Impact factor: 1.451
Authors: G J Ruiz-Argüelles; J Garcés-Eisele; V Reyes-Núñez; B Pérez-Romano; A Ruiz-Argüelles; F J Ramírez-Cisneros; B López-Martínez; J D López-Tapia; L Rivadeneyra-Espinoza Journal: Rev Invest Clin Date: 2000 Mar-Apr Impact factor: 1.451
Authors: G J Ruiz-Argüelles; E Lobato-Mendizábal; J F San-Miguel; M González; M D Caballero; A Ruiz-Argüelles; A Orfao; D Gómez-Almaguer; B Vidriales; G Ruiz-Reyes Journal: Br J Haematol Date: 1992-12 Impact factor: 6.998
Authors: J S Velarde-Félix; J Sanchez-Zazueta; F P Gonzalez-Ibarra; J A González-Valdez; B Salcido-Gómez; E Gallardo-Angulo; J Murillo-Llanes Journal: West Indian Med J Date: 2014-06-10 Impact factor: 0.171